Stanley Lapidus
CIK: 0001678195
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LUCD
Lucid Diagnostics Inc.
Director
Discretionary Trading P&L
Holdings
About Lapidus Stanley
Lapidus Stanley (SEC CIK 0001678195) files insider reports with the SEC as Director of Lucid Diagnostics Inc. (LUCD).
Signal8 holds 2 ownership filings by Lapidus Stanley, all Form 4s, filed between Feb 21, 2025 and Feb 24, 2026. Those filings report 2 transactions, from Feb 20, 2025 to Feb 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lapidus Stanley's filings is in NEW YORK, NY.
Recent filings by Lapidus Stanley
Other insiders filing for Lucid Diagnostics Inc. (LUCD)
- Matheis Dennis, Director
- Lee Victoria Tou-ho, Chief Medical Officer
- Aklog Lishan, Chief Executive Officer
- White Debra, Director
- Sparks Ronald M, Director
- SOKOLOV JACQUE J, Director